Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Katie's Way Plus is a specialized mental health healthcare provider that focuses on interventional psychiatry and advanced behavioral health treatments. The organization offers innovative therapeutic options such as Transcranial Magnetic Stimulation (TMS) and Spravato (esketamine) nasal spray, specifically targeting patients with treatment-resistant depression. In addition to these advanced modalities, the company provides comprehensive psychiatric diagnostic assessments, medication management, and therapy services. Katie's Way Plus operates several clinical locations across Kansas, aiming to bridge the gap between traditional mental health care and cutting-edge neurostimulation technologies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Katie's Way Plus.